EyePoint (EYPT) Net Margin Growth (3y) (2013 - 2026)
EyePoint (EYPT) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 | -1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.70 Mn |
| Dec 31, 2025 | -1.05 Mn |
| Sep 30, 2025 | -527,976.00 |
| Jun 30, 2025 | -32,014.00 |
| Mar 31, 2025 | -420.00 |
| Dec 31, 2024 | -18,467.00 |
| Sep 30, 2024 | -9,463.00 |
| Jun 30, 2024 | -18,819.00 |
| Mar 31, 2024 | -67,181.00 |
| Dec 31, 2023 | 10,913.00 |
| Sep 30, 2023 | -13,918.00 |
| Jun 30, 2023 | -7,034.00 |
| Mar 31, 2023 | -11,374.00 |
| Dec 31, 2022 | -25,264.00 |
| Sep 30, 2022 | -27,275.00 |
| Jun 30, 2022 | -63,101.00 |
| Mar 31, 2022 | 57,325.00 |
| Dec 31, 2021 | 72,225.00 |
| Sep 30, 2021 | 120,357.00 |
| Jun 30, 2021 | 74,302.00 |